Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH‐wildtype glioblastoma

OBJECTIVE: Accumulating evidence from recent molecular diagnostic studies has indicated the prognostic significance of various genetic markers for patients with glioblastoma (GBM). To evaluate the impact of such genetic markers on prognosis, we retrospectively analyzed the outcomes of patients with...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Med
Hlavní autoři: Funakoshi, Yusuke, Hata, Nobuhiro, Takigawa, Kosuke, Arita, Hideyuki, Kuga, Daisuke, Hatae, Ryusuke, Sangatsuda, Yuhei, Fujioka, Yutaka, Sako, Aki, Umehara, Toru, Yoshitake, Tadamasa, Togao, Osamu, Hiwatashi, Akio, Yoshimoto, Koji, Iwaki, Toru, Mizoguchi, Masahiro
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2021
Témata:
Clinical Cancer Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8124111/
https://ncbi.nlm.nih.gov/pubmed/33838014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3860
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky